- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PF-04383119 (tanezumab)
Total 1344 results
-
PfizerTerminatedAlzheimer's DiseaseUnited States
-
PfizerCompletedType 2 Diabetes PatientsUnited States
-
PfizerCompletedAlzheimer's DiseaseUnited States, Sweden
-
PfizerCompletedRespiratory Tract InfectionsUnited States
-
PfizerCompletedHealthy VolunteersUnited States
-
PfizerTerminatedRenal Cell Carcinoma | Non-small-cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck | Urothelial Carcinoma | Colorectal Carcinoma | Ovarian CarcinomaUnited States
-
Telavant, Inc.PfizerCompleted
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerCompletedChronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS)United States
-
PfizerCompletedCarcinoma, Non Small Cell LungKorea, Republic of
-
PfizerYale UniversityCompleted
-
Ronald LevyPfizerCompletedLymphoma | Lymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Follicular / Indolent B-CellUnited States
-
PfizerCompletedCrohn's DiseaseUnited States, Denmark, Ireland, Australia, Belgium, Israel, Italy, Canada, Czech Republic, Hungary, Germany, United Kingdom, Brazil, New Zealand, France, Greece, Switzerland, Romania
-
PfizerCompleted
-
PfizerYale UniversityCompleted
-
PfizerIncyte CorporationCompleted
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompleted
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingStage IB Non-Small Cell Lung Carcinoma AJCC v7 | Stage II Non-Small Cell Lung Cancer AJCC v7 | Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | ALK Gene Rearrangement | ALK Gene Translocation | ALK...United States, Guam, Puerto Rico
-
PfizerCompletedDermatitis, AtopicUnited States, Hungary, Canada, Germany, Australia, Czechia, Poland, United Kingdom
-
PfizerCompletedNon-Small Cell Lung CarcinomaTaiwan
-
PfizerCompletedHealthy ParticipantsUnited States
-
PfizerActive, not recruiting
-
SIFI SpACompleted
-
Pierre Fabre MedicamentCompletedMelanoma | BRAF V600E Unresectable or Metastatic Melanoma | BRAF V600E Metastatic NSCLCChina
-
BiogenCompleted
-
BiogenCompletedHearing Loss, SensorineuralUnited States
-
BiogenCompleted
-
PfizerCompleted
-
PfizerCompletedHealthy SubjectsUnited States
-
PfizerTerminated
-
PfizerTerminatedType 2 Diabetes MellitusUnited States
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompletedAtopic DermatitisUnited States, Canada
-
PfizerCompletedActive Non-segmental VitiligoSpain, United States, Korea, Republic of, Taiwan, Canada, Australia, Germany, Japan, Belgium, Italy
-
PfizerCompletedDermatitis, AtopicChina, United States, Australia, Poland, Hungary, Korea, Republic of, Germany, Bulgaria, Canada, Czechia, Japan, Latvia, United Kingdom
-
PfizerCompletedViral DiseaseUnited States, Spain, Brazil, Belgium
-
PfizerWithdrawn
-
PfizerCompleted
-
PfizerCompletedRheumatoid ArthritisUnited States, Spain, Czechia, Serbia, Singapore, Taiwan, Hungary, Ukraine, Hong Kong, Korea, Republic of, Russian Federation, Slovakia, Turkey
-
Children's Oncology GroupNational Cancer Institute (NCI); PfizerCompletedRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Anaplastic Large Cell Lymphoma | Recurrent Childhood Anaplastic Large Cell LymphomaUnited States, Canada
-
PfizerNot yet recruiting